DK111277B - Fremgangsmåde til stabilisering af 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-on. - Google Patents

Fremgangsmåde til stabilisering af 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-on.

Info

Publication number
DK111277B
DK111277B DK425066AA DK425066A DK111277B DK 111277 B DK111277 B DK 111277B DK 425066A A DK425066A A DK 425066AA DK 425066 A DK425066 A DK 425066A DK 111277 B DK111277 B DK 111277B
Authority
DK
Denmark
Prior art keywords
benzodiazepin
dihydro
nitro
stabilizing
phenyl
Prior art date
Application number
DK425066AA
Other languages
English (en)
Inventor
Hoffmann La Roche & Co Ag F
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK111277B publication Critical patent/DK111277B/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heat-Exchange Devices With Radiators And Conduit Assemblies (AREA)
DK425066AA 1965-08-20 1966-08-19 Fremgangsmåde til stabilisering af 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-on. DK111277B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1177965 1965-08-20

Publications (1)

Publication Number Publication Date
DK111277B true DK111277B (da) 1968-07-15

Family

ID=4376790

Family Applications (1)

Application Number Title Priority Date Filing Date
DK425066AA DK111277B (da) 1965-08-20 1966-08-19 Fremgangsmåde til stabilisering af 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-on.

Country Status (14)

Country Link
JP (1) JPS507079B1 (da)
BE (1) BE685589A (da)
DE (1) DE1617513C3 (da)
DK (1) DK111277B (da)
ES (1) ES330391A1 (da)
FI (1) FI45726C (da)
FR (1) FR6063M (da)
GB (1) GB1101366A (da)
IL (1) IL26306A (da)
IT (1) IT1053660B (da)
MY (1) MY6900059A (da)
NL (1) NL6610569A (da)
NO (1) NO120752B (da)
SE (1) SE351978B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020031490A1 (en) * 2000-07-27 2002-03-14 Bellamy Simon Andrew Method for preparing resinates
US20020032245A1 (en) * 2000-07-27 2002-03-14 Lyn Hughes Resinate composition
US20030059397A1 (en) * 2001-09-17 2003-03-27 Lyn Hughes Dosage forms
EP1467769B1 (en) * 2002-01-18 2008-05-28 Rohm and Haas Company Use of a resinate in the preparation of a formulation for smoking cessation

Also Published As

Publication number Publication date
FI45726C (fi) 1972-09-11
ES330391A1 (es) 1967-10-16
IT1053660B (it) 1981-10-10
NO120752B (da) 1970-11-30
DE1617513A1 (de) 1970-12-23
IL26306A (en) 1970-02-19
NL6610569A (da) 1967-02-21
FR6063M (da) 1968-05-27
GB1101366A (en) 1968-01-31
DE1617513C3 (de) 1974-04-18
BE685589A (da) 1967-02-17
SE351978B (da) 1972-12-18
JPS507079B1 (da) 1975-03-20
DE1617513B2 (de) 1973-08-16
FI45726B (da) 1972-05-31
MY6900059A (en) 1969-12-31

Similar Documents

Publication Publication Date Title
DK120546B (da) Fremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimidiner.
DK117631B (da) Fremgangsmåde til fremstilling af 20-oxopregnan-, 20-oxo-4-pregnen- eller 20-oxo-5(6)-pregnen-(17α, 16α-d)-oxazoliner.
DK116441B (da) Fremgangsmåde til fremstilling af 10,11-dihydro-dibenzo-(b,f)-thiepinderivater.
DK112523B (da) Fremgangsmåde til fremstilling af 2,3-pyridindiol.
DK125856B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepiner.
DK113915B (da) Fremgangsmåde til stabilisering af halogenerede carbonhydrider.
DK111277B (da) Fremgangsmåde til stabilisering af 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-on.
DK116511B (da) Fremgangsmåde til fremstilling af substituerede 1,4-benzodiazepinforbindelser.
DK124823B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater.
DK121759B (da) Analogifremgangsmåde til fremstilling af 3-oxo-7α-methylgona-4,9-diener.
DK115106B (da) Fremgangsmåde til rensning af 2,2,2-trifluor-1-klor-1-bromætan.
DK115184B (da) Fremgangsmåde til fremstilling af 6,7-benzomorphaner.
DK116219B (da) Fremgangsmåde til fremstilling af 1,2,4-triazoler.
DK117499B (da) Fremgangsmåde til fremstilling af 1,3-dihydro-3-hydroxy-1,4-benzodiazepin-2-oner.
DK128279B (da) Fremgangsmåde til fremstilling af α,ω-alkylendiaminer.
DK112031B (da) Fremgangsmåde til fremstilling af 3,20-dioxo-17α-methyl-19-nor-pregna-4,9,11-trien.
DK122079B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater.
DK126115B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater.
DK117956B (da) Fremgangsmåde til fremstilling af 3-oxogona-4,9-diener.
DK114204B (da) Fremgangsmåde til fremstilling af carboxamidoalkyl-1,3-benzoxaziner.
DK120395B (da) Fremgangsmåde til fremstilling af 1-[5-nitrothiazolyl-(2)]-2-oxo-tetrahydro-imidazoler.
DK127253B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepiner.
DK113917B (da) Fremgangsmåde til fremstilling af 2,2,6,6-tetrachlorcyclohexanon.
DK115998B (da) Fremgangsmåde til fremstilling af 3H-1,4-benzodiazepin-2-on-forbindelser.
DK124949B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater.